ABSTRACT
The framework in this chapter will provide an effective solution to formulating a well-structured value story and supporting messages that are focused and compelling. Optimizing the commercial potential of the prescription drug portfolio requires communications between the commercial and development teams in the company that go far beyond the Food and Drug Administration and European Medicines Agency considerations that are often still the cornerstone of clinical trials’ design decisions. Many companies are putting significant efforts in creating a value dossier. The TEMPLE framework is based on the concept that we need to create both an early interest and a strong rationale for meaningful claims that our new drug brings to payers and other important players in the drug prescribing decision process. Cost and budget impact is a prime concern for most new drugs or treatments. Objection handling is an important component of payer value story development.
